Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis
Authors
Keywords
Vaccination and immunization, Human papillomavirus infection, Human papillomavirus, Cancer vaccines, Cancers and neoplasms, Cervical cancer, Cost-effectiveness analysis, Vaccines
Journal
PLOS MEDICINE
Volume 18, Issue 3, Pages e1003534
Publisher
Public Library of Science (PLoS)
Online
2021-03-12
DOI
10.1371/journal.pmed.1003534
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices
- (2019) Elissa Meites et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Effectiveness and Cost-Effectiveness of Human Papillomavirus Vaccination Through Age 45 Years in the United States
- (2019) Jean-François Laprise et al. ANNALS OF INTERNAL MEDICINE
- Cost-effectiveness of nonavalent HPV vaccination among males aged 22 through 26 years in the United States
- (2018) Harrell W. Chesson et al. VACCINE
- Screening for Cervical Cancer in Primary Care
- (2018) Jane J. Kim et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Screening for Cervical Cancer
- (2018) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials
- (2018) M. Arbyn et al. Expert Review of Vaccines
- Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study
- (2016) Cosette M Wheeler et al. LANCET INFECTIOUS DISEASES
- National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2015
- (2016) Sarah Reagan-Steiner et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- US Assessment of HPV Types in Cancers: Implications for Current and 9-Valent HPV Vaccines
- (2015) Mona Saraiya et al. JNCI-Journal of the National Cancer Institute
- A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women
- (2015) Elmar A. Joura et al. NEW ENGLAND JOURNAL OF MEDICINE
- US Assessment of HPV Types in Cancers: Implications for Current and 9-Valent HPV Vaccines
- (2015) Mona Saraiya et al. JNCI-Journal of the National Cancer Institute
- National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2014
- (2015) Sarah Reagan-Steiner et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Human Papillomavirus Genotype-Specific Prevalence across the Continuum of Cervical Neoplasia and Cancer
- (2014) N. E. Joste et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Cervical excisional treatment of young women: A population-based study
- (2014) Walter Kinney et al. GYNECOLOGIC ONCOLOGY
- Human papillomavirus testing 2007-2012: Co-testing and triage utilization and impact on subsequent clinical management
- (2014) Jack Cuzick et al. INTERNATIONAL JOURNAL OF CANCER
- Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold
- (2014) Peter J. Neumann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of the HPV-16/18 vaccine: Final according to protocol results from the blinded phase of the randomized Costa Rica HPV-16/18 vaccine trial
- (2014) Allan Hildesheim et al. VACCINE
- A Population-Based Evaluation of Cervical Screening in the United States: 2008-2011
- (2013) J. Cuzick et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- 2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors
- (2013) L. Stewart Massad et al. Journal of Lower Genital Tract Disease
- American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer
- (2012) Debbie Saslow et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A population-based study of human papillomavirus genotype prevalence in the United States: Baseline measures prior to mass human papillomavirus vaccination
- (2012) Cosette M. Wheeler et al. INTERNATIONAL JOURNAL OF CANCER
- End-of-study safety, immunogenicity and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of age
- (2011) X Castellsagué et al. BRITISH JOURNAL OF CANCER
- Projections of the Cost of Cancer Care in the United States: 2010-2020
- (2011) A. B. Mariotto et al. JNCI-Journal of the National Cancer Institute
- Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males
- (2011) Anna R. Giuliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- The psychosocial impact of an abnormal cervical smear result
- (2011) Mélanie Drolet et al. PSYCHO-ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search